{
    "code": 0,
    "data": [
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised Results H1 2026",
            "news_body": "Revised Results H1 2026",
            "news_id": "e9072710-8849-4462-b582-5171dc3aa6aa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee0634e5-8fd0-42c1-908f-57986b3edbab.pdf",
            "news_date": "2025-11-13 22:11:31",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results H1 2025",
            "news_body": "Results H1 2025",
            "news_id": "36faa2ee-3167-4a85-85ad-455d72eb4018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be62f17d-2494-442d-9aa9-9bef0cdb13eb.pdf",
            "news_date": "2025-11-13 21:14:08",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "b9f8a163-944f-4c2c-8c4e-33df9a74df59",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92488773-6e8e-45ed-a2f2-3c892d1d16c8.pdf",
            "news_date": "2025-08-13 22:34:04",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results FY2025",
            "news_body": "Results FY2025",
            "news_id": "aa997525-eb83-4de0-a8db-ee9f1f35511c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa1e7178-75df-4a8f-8b6f-5dad2810c92e.pdf",
            "news_date": "2025-05-31 00:18:16",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Q3 Results FY2025",
            "news_body": "Q3 Results FY2025",
            "news_id": "60ab8ed9-4216-472d-ac10-44fc79bcb0d8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38c02434-e6e8-4e87-9c7f-5ab3cdb0ca31.pdf",
            "news_date": "2025-02-14 21:28:46",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Resultsh1fy2025",
            "news_body": "ResultsH1FY2025",
            "news_id": "8e6cfb8c-513f-4479-9ca4-e472b35d2818",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab34c3dd-aefe-4e9e-8289-8dd965b4b081.pdf",
            "news_date": "2025-01-11 00:09:55",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Resultsq1fy2025",
            "news_body": "ResultsQ1FY2025",
            "news_id": "53bd5257-9f81-4d0e-9a39-7e021108692b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4622b1b1-5ae6-4b02-bd00-6139b589b8c5.pdf",
            "news_date": "2025-01-11 00:08:04",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "a23b67b1-bb47-4972-9262-26b3502862dc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cffa3b6-7d28-4558-92ba-5354967ddf25.pdf",
            "news_date": "2024-11-14 22:37:57",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Delay in Financial Results",
            "news_body": "Non-Compliance with Regulation 33 of SEBI (LODR) Regulations 2015 for the period/ year ended June, 2024",
            "news_id": "0c391c83-e5d1-4ccf-a833-a78ccaf80c01",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c849c1f9-dda9-4fa6-bc35-9d7876816e1a.pdf",
            "news_date": "2024-08-22 14:53:31",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Meeting Of The Board Of Directors Of The Company",
            "news_body": "Results Q3FY24",
            "news_id": "86070069-22a4-49b5-94e3-b40df356cb37",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c1ab2fe-d8e9-4bed-90be-bd339d111674.pdf",
            "news_date": "2024-02-14 19:37:16",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results 30.09.2023",
            "news_body": "Results 30.09.2023",
            "news_id": "8ade4935-ff1d-4506-b0a7-3bcbdd09eb1d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0628242a-5b44-4b28-9d7e-6528f3d3632f.pdf",
            "news_date": "2023-11-14 21:11:53",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting- Audited Financial Results For The Quarter And Yearended 31 March, 2023",
            "news_body": "Outcome of Board Meeting- Audited financial results for the quarter and yearended 31 March, 2023",
            "news_id": "fd15fba3-90fa-4340-a48e-44e260de94ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e64fec10-1bfb-4b93-888a-87fec2d019dd.pdf",
            "news_date": "2023-05-30 23:31:11",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "The Board of Directors of the Company at its meeting held on February 13, 2023 inter alia, have approved / resolved/ taken note of the following:<BR> <BR> 1. Considered and approved the submission of the Un-audited Financial Results (Standalone & Consolidated) for the Quarter and nine months ended December 31, 2022 attached herewith;<BR> <BR> 2. Auditors's Limited Review Report on the Un-audited Financial Statements of the Company for the Quarter and nine months ended December 31, 2022.<BR> <BR> 3. Directors Report for the financial year ended 31.03.2022 together with annexure thereto.<BR> <BR> 4. Convening of Annual General Meeting (AGM) on 18.03.2023 and Notice of AGM.<BR> <BR> 5. Fixed Book closure dates from Monday, March 13, 2023 to Saturday, March 18, 2023 (both days inclusive) for the purpose of AGM.<BR> <BR> The Board Meeting concluded at 6.00 P.M.<BR> <BR>",
            "news_id": "26aadea1-8892-4038-bf95-3f2d0503dd7f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0e52d77-e622-491c-b2c7-4466193410af.pdf",
            "news_date": "2023-02-13 18:05:29",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Revised - Outcome Of The Meeting Of The Board Of Directors Of The Company",
            "news_body": "Revised - Outcome of the Meeting of the Board of Directors of the Company <BR> In relation to Board meeting end time",
            "news_id": "c86a77e0-7c79-43f4-a310-be9bef45b5c9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19ca9382-dfb4-4045-9717-2eaaff200768.pdf",
            "news_date": "2022-11-18 12:48:30",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Meeting Of The Board Of Directors Of The Company",
            "news_body": "Outcome of the Meeting of the Board of Directors of the Company",
            "news_id": "87faf667-ab11-4461-a830-68a7e98fe8f8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97a1a95c-bbdd-4b80-b0c2-64b2bd402e81.pdf",
            "news_date": "2022-11-14 20:29:23",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Meeting Of The Board Of Directors Of The Company",
            "news_body": "Outcome of the Meeting of the Board of Directors of the Company",
            "news_id": "0d9c720a-fa43-4e1b-bcb1-4fae9c6d90a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8f64a9b-414c-4c77-bcbf-ed40f242a9b6.pdf",
            "news_date": "2022-08-12 21:03:50",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting- Audited Financial Results For The Quarter And Year Ended 31 March, 2022",
            "news_body": "Outcome of Board Meeting- Audited financial results for the quarter and year ended 31 March, 2022",
            "news_id": "942f79f0-83d5-4ad1-b3c2-a6da5a7e54e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a233ae8-1de0-4b90-8377-22528cf5b89f.pdf",
            "news_date": "2022-06-04 01:23:14",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Meeting Of The Board Of Directors Of The Company",
            "news_body": "Outcome of the Meeting of the Board of Directors of the Company",
            "news_id": "47c8f5e8-1f60-41b4-a524-8d14ca8e4e9b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=245a65e9-48b8-4009-a0d0-6f45a0289a0a.pdf",
            "news_date": "2022-02-14 16:57:19",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Meeting Of The Board Of Directors Of The Company",
            "news_body": "The Board of Directors of the Company at its meeting held on November 13, 2021 inter alia, have approved / resolved/ taken note of the following:<BR> <BR> 1. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 considered and approved the submission of the Un-audited Financial Results (Standalone & Consolidated) for the Quarter and half year ended September 30, 2021 attached herewith;<BR> <BR> 2. Auditors's Limited Review Report on the Un-audited Financial Results of the Company for the quarter and half year ended September 30, 2021.<BR> <BR> 3. Resignation of CEO cum CFO (Mr.Ramesh Krishnamurthy).<BR>",
            "news_id": "4aaeac26-aa0a-40b5-9060-69c668801c83",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cbeadc4-d73f-4ae3-aa18-8080806f16aa.pdf",
            "news_date": "2021-11-13 16:50:55",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting- Un-Audited Financial Results For The Quarter Ended 30 June, 2021",
            "news_body": "The Board of Directors of the Company at its meeting held on August 13, 2021 inter alia, have approved / resolved/ taken note of the following:<BR> <BR> 1. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 considered and approved the submission of the Un-audited Financial Results (Standalone & Consolidated) for the Quarter ended June 30, 2021 attached herewith;<BR> <BR> 2. Auditors's Limited Review Report on the Un-audited Financial Statements of the Company for the quarter ended June 30, 2021.<BR> <BR> 3. Directors Report for the financial year ended 31.03.2021 together with annexure thereto.<BR> <BR> 4. Convening of Annual General Meeting (AGM) on 30.09.2021 and Notice of AGM.<BR> <BR> 5. Fixed Book closure dates from Saturday, September 25, 2021 to Thursday, September 30, 2021 (both days inclusive) for the purpose of AGM.<BR>  <BR> You are requested to take note of the above.<BR>",
            "news_id": "17d547e7-5db8-422e-a715-b1ba823f021d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c388dc96-109a-4010-8ad8-d9e249d6c20f.pdf",
            "news_date": "2021-08-13 21:07:11",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised Outcome Of Board Meeting- Audited Financial Results For The Quarter And Year Ended 31 March, 2021",
            "news_body": "Revised Outcome of Board Meeting- Audited financial results for the quarter and year ended 31 March, 2021",
            "news_id": "c24c4a6a-c4f4-4fc1-bd37-54a27fc4fe7a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e75d5885-6a36-4c8f-80cc-0e636bc136f4.pdf",
            "news_date": "2021-06-30 12:47:41",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting- Audited Financial Results For The Quarter And Year Ended 31 March, 2021",
            "news_body": "Outcome of Board Meeting- Audited financial results for the quarter and year ended 31 March, 2021",
            "news_id": "216cce95-24f3-444e-9a79-29d89d2360e3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=704e8e8a-714d-42fc-b1d5-d493e587926d.pdf",
            "news_date": "2021-06-28 22:31:08",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "VIVIMEDLAB",
            "disp": "Vivimed Labs",
            "bse_code": 532660,
            "isin": "INE526G01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": ":  Outcome Of The Meeting Of The Board Of Directors Of The Company",
            "news_body": ":  Outcome of the Meeting of the Board of Directors of the Company",
            "news_id": "c0c572dd-1794-49de-bf44-52d1e3272c62",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53a551ef-b5db-40a1-b3e1-3977355b61ee.pdf",
            "news_date": "2021-02-13 15:36:46",
            "seo": "vivimed-labs-ltd",
            "ltp": 6.8,
            "ch": -0.35000000000000053,
            "pch": -4.895104895104902,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11965,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}